Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.
Dayton Children's Hospital - $69,600
$69,600.00 USD
November 2019
Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.
Institute of Cancer Research - $121,863
$121,863.00 USD
November 2019
Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.
Bambino Gesu Children's Hospital - $49,803
$49,803.00 USD
August 2019
Using imaging mass cytometry to identify next generation imaging biomarkers in PHGG and DIPG.
Telethon Kids Institute - $49,512 USD / $69,822 AUD (Approx)
$49,512.00 USD
August 2019
Development of a new and effective therapy against Diffuse Intrinsic Pontine Glioma.
Oncoceutics ONC201 - Phase II - $83,333
$83,333.00 USD
May 2019
Expansion of the ONC201 Compassionate Use.
Funding of PBTCF 2019: PBTC-058 - $25,000
$25,000.00 USD
January 2019
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children’s Hospital - $175,089 USD / $242,388 AUD (Approx)
$175,089.00 USD
November 2018
Polyamine Pathway Metabolism as a Novel Therapeutic Option for Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital - $540,742
$540,742.00 USD
November 2018
Expansion of the International DIPG Registry.
Bambino Gesú Children's Hospital - $99,382
$99,382.00 USD
November 2018
Investigating the Role of DIPG-Derived Exosomes in Tumor Growth and Invasion.
Ann and Robert H. Lurie Children's Hospital of Chicago - $35,000
$35,000.00 USD
November 2018
Credentialing an Improved DIPG Mouse Model.
Oncoceutics ONC201 - $83,333
$83,333.00 USD
October 2018
Expansion of the ONC201 Compassionate Use.
The Institute of Cancer Research - $100,000
$100,000.00 USD
October 2018
Short-pulse Ultrasound Delivery of Panobinostat for the Treatment of Diffuse Intrinsic Gliomas in Children
The Institute of Cancer Research - $106,647
$106,647.00 USD
October 2018
A Mouse Model of HIST1H3B/ACVR1 Mutant DIPG.
Johns Hopkins Children's Center - $50,000
$50,000.00 USD
July 2018
Using Zebrafish to Accelerate DIPG Drug Development.
Funding of PBTCF 2018: PBTC-058 - $16,800
$16,800.00 USD
January 2018
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma